Noncoding regions of genome targeted by CRISPR

Anna Azvolinsky, The Scientist, 29 September 2016,

Researchers from Harvard, MIT and the Broad Institute have used CRISPR technology to study regulatory elements of the genome.  The overriding goal of these studies is to develop rules for how non-coding sections of the genome impact coding regions, as well as discover potential drug targets and how genetic changes in the non-coding regions can affect drug resistance.

Author: Advanced Analytical

Advanced Analytical Technologies, Inc. (AATI) simplifies complex genomics workflows to accelerate research and discovery in pharmaceuticals, life science, biofuels, biotechnology and healthcare.

Leave a Reply